NIH – Melanoma Clinical Trials September 2013

Melanoma Clinical Trials – Recruiting Phase
NCT01814046

Adoptive T Cell Therapy for Metastatic Ocular Melanoma

Phase 2
NCT01369888

Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma

Phase 1|Phase 2
NCT00304460

Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer

Phase 1
NCT01021059

A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer

 Phase 1
NCT01468818

A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotrheraphy Regimen in Metastatic Melanoma

Phase 2
NCT01495572

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Phase 2
NCT01319565

Prospective Randomized Study of Cell Therapy for Metastatic Melanoma Using Short-Term Cultured Tumor Infiltrating Lymphocytes Plus IL-2 Following Either a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Alone or in Conjunction w/1200 TBI

Phase 2
1NCT01313429

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Phase 1
NCT01585415

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Phase 1
NCT01341496

Tumor Cell Vaccines and ISCOMATRIX(Trademark) With Chemotherapy After Tumor Removal

Phase 1
NCT01336985

Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads

Phase 1
NCT00670748

Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer

Phase 2
NCT01218867

Treating Metastatic Cancer With Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes

Phase 1|Phase 2
NCT00720785

Natural Killer Cells and Bortezomib to Treat Cancer

Phase 1
Advertisements

Leave a comment

Filed under Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s